NEW YORK (

TheStreet

) --

Vertex Pharmaceuticals

(Nasdaq:

VRTX

) hit a new 52-week low Friday as it is currently trading at $26.76, below its previous 52-week low of $26.89 with 217,012 shares traded as of 10:46 a.m. ET. Average volume has been 3.5 million shares over the past 30 days.

Vertex has a market cap of $5.82 billion and is part of the

health care

sector and

drugs

industry. Shares are down 23.1% year to date as of the close of trading on Wednesday.

Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Vertex as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full

Vertex Ratings Report

.

See all

52-week low stocks

or get investment ideas from our

investment research center

.

null